home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Overview of FDA Regulatory Compliance For Medical Devices

 
  December 11, 2009  
     
 
The Center for Professional Innovation & Education, Dublin, Ireland
March 22 & 23, 2010


Who Should Attend

This course was developed for those who are involved with ensuring regulatory compliance for medical devices.  Typical attendees include those in:
  • Manufacturing
  • Regulatory Affairs
  • Product Design
  • Research and Development
  • Quality Assurance & Control
  • Development and Preparation of Submission Material
  • Laboratory Operations

This course is designed for individuals who require in-depth knowledge of regulatory affairs and compliance issues.  The course content is continually updated by our expert Course Directors.  When delivered as an in-house program, this course is fully customizable to meet the specific needs of an organization, department or employees functional responsibility.



Learning Objectives

This course is specifically focused on the law, regulations and policies set down by the FDA for the manufacture of medical devices.  It will provide each attendee with the background and knowledge necessary to understand the organization, structure and role of the FDA as it relates to pre-marketing approval processes and compliance issues for medical devices.  The course content is designed to provide an in-depth understanding of the paths to obtaining agency approval, how the FDA performs inspections, the type of information they are looking to see in place and the variety of outcomes from each inspection.  The course also covers the remedies available to satisfy inspectors that manufacturing processes are fully in compliance with quality system requirements.



Course Description

This course discusses the Agency’s regulatory authority for approving medical devices prior to marketing and the compliance programs used in enforcing its authorities. It also provides FDA strategies towards inspections of manufacturing sites and compliance actions that may result from these. The various regulatory processes are presented including the major enforcement tools such as warning letter, injunctions and civil money penalties. The course provides the attendees with the most important regulatory resource materials needed to understand agency behavior. 

Issues to be covered include:

  • Structure of the FDA
  • Current FDA regulatory compliance practices
    • How to work with FDA Investigators
    • The regulatory approval process – “what the FDA is looking for” in 510ks, PMAs and other pre-approval applications
  • The scope of FDA’s compliance programs, policies and potential enforcement actions
  • Discussion of post-marketing notification and reporting programs
  • Strategies for development of an in-house compliance program for GMP’s and ensure successful inspectional outcomes.
  • Recent FDA enforcement statistics
 
 
Organized by: Center for Professional Innovation & Education
Invited Speakers: info@cfpie.com
 
Deadline for Abstracts: n/a
 
Registration: http://www.cfpie.com/showitem.aspx?productid=020&source=hummolgen
E-mail: info@cfpie.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.